• Issue

    Nephrology: Volume 23, Issue 6

    497-605
    June 2018

Issue Information

Free Access

Issue Information

  • Pages: 497-499
  • First Published: 10 June 2018

Review Articles

PROGRESSIVE CHRONIC RENAL DISEASE

Free Access

Known unknowns: Examining the burden of neurocognitive impairment in the end-stage renal failure population

  • Pages: 501-506
  • First Published: 18 January 2018
Summary at a Glance

This paper reviews neurocognitive impairment in ESRD patients. This issue is increasingly recognized and is becoming clinically important.

Free Access

Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand

  • Pages: 507-517
  • First Published: 08 February 2018
Summary at a Glance

The management of thrombotic microangiopathy (TMA) is challenging; this consensus approach from Australia and New Zealand provides a practical strategy for diagnosing and treating patients with TMA.

Original Articles

PROGRESSIVE CHRONIC RENAL DISEASE

Predictors of complication following lower extremity amputation in diabetic end-stage renal disease

  • Pages: 518-522
  • First Published: 26 April 2017
Summary at a Glance

Although not a pathbreaking work, the paper handles a complex problemthat has not been studied in significant detail. Thus it adds valuable information to the pool of knowledge in the area.

Simple risk score for prediction of haemorrhagic complications after a percutaneous renal biopsy

  • Pages: 523-529
  • First Published: 16 April 2017
Summary at a Glance

The authors, using experience from a single centre, derive a point based “risk” score, which can aid in determining an individual's risk for a major complication following percutaneous renalbiopsy of the native kidney.

ACUTE RENAL DISEASE

N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis

  • Pages: 530-538
  • First Published: 27 April 2017
Summary at a Glance

Contrast-induced nephropathy (CIN) is a common and serious side effect in patients undergoing cardioangiography or radiological procedures. N-acetylcysteine is an option in preventing CIN.

Practical issues in using eculizumab for children with atypical haemolytic uraemic syndrome in the acute phase: A review of four patients

  • Pages: 539-545
  • First Published: 07 April 2017
Summary at a Glance

This manuscript describes practical issues in using eculizumab for children with atypical haemolytic uraemic syndrome (aHUS). Since clinical information on the use of eculizumab for children with aHUS are limited, and the rationale for its long-term use has yet to be established, this study would provide helpful information for clinicians.

DIALYSIS

Loss of appendicular muscle mass in haemodialysis patients is associated with increased self-reported depression, anxiety and lower general health scores

  • Pages: 546-551
  • First Published: 25 May 2017
Summary at a Glance

Although not something that changes practice, it does examine an aspect that is not often studied. It does contribute to what clinician see every day, depressed patients fare worse.

Hypothyroidism is associated with all-cause mortality in a national cohort of chronic haemodialysis patients

  • Pages: 559-564
  • First Published: 27 March 2017
Summary at a Glance

Hypothyroidism is associated with increased all-cause mortality in chronic HD patients in Taiwan. Thyroxin replacement therapy lowers the risk of mortality in a time-varying Cox proportional hazard regression analysis.

CLINICAL GLOMERULONEPHRITIS

Causes of nephrotic syndrome and nephrotic-range proteinuria are different in adult Chinese patients: A single centre study over 33 years

  • Pages: 565-572
  • First Published: 20 April 2017
Summary at a Glance

A single-centre study examining the spectrum of histopathological diagnoses in patients with nephrotic syndrome and nephrotic range proteinuria over a 30-year period.

PATHOLOGY,IMMUNOLOGY AND INFLAMMATION

Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction

  • Pages: 573-584
  • First Published: 24 April 2017
Summary at a Glance

An interesting manuscript which investigates whether fluorofenidone (one of the pyridine agents) could ameliorate kidney fibrosis process in UUO model by regulating the interaction of NLRP3 inflammasome-assembly and the inhibition of IL-1B production.

TRANSPLANTATION

Age-specific risk of renal graft loss from late acute rejection or non-compliance in the adolescent and young adult period

  • Pages: 585-591
  • First Published: 27 April 2017
Summary at a Glance

The manuscript highlights important issues relating to kidney transplant outcome during the young adolescent and the early adulthood period. Accepting the limitations of the study which uses registry acquired data, the manuscript demonstrates significant graft loss throughout the time period relating to age; however, transition from paediatric care to young adulthood was not a specific risk factor.